BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28551312)

  • 21. Comparison between the ICRU rectal point and modern volumetric parameters in brachytherapy for locally advanced cervical cancer.
    Mazeron R; Kamsu Kom L; Rivin del Campo E; Dumas I; Farha G; Champoudry J; Chargari C; Martinetti F; Lefkopoulos D; Haie-Meder C
    Cancer Radiother; 2014 Jun; 18(3):177-82. PubMed ID: 24751222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose to pelvic lymph nodes during brachytherapy of locally advanced cervical cancer with 60Co HDR source.
    Siavashpour Z; Aghili M; Anjidani S; Zayeri F; Moghani MM; Maleki M; Jaberi R
    Brachytherapy; 2022; 21(2):158-169. PubMed ID: 34750084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy.
    Bockel S; Escande A; Dumas I; Manea E; Morice P; Gouy S; Deutsch E; Haie-Meder C; Chargari C
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30669569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-effect response in image-guided adaptive brachytherapy for cervical cancer: A systematic review and meta-regression analysis.
    Tang X; Mu X; Zhao Z; Zhao H; Mao Z
    Brachytherapy; 2020; 19(4):438-446. PubMed ID: 32265118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of planning aims and dose prescription in image-guided adaptive brachytherapy and radiochemotherapy for cervical cancer: Vienna clinical experience in 225 patients from 1998 to 2008.
    Majercakova K; Pötter R; Kirisits C; Banerjee S; Sturdza AE; Georg P; Nesvacil N; Schmid MP
    Acta Oncol; 2015; 54(9):1551-7. PubMed ID: 26198658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancer.
    Biltekin F; Gultekin M; Yilmaz MT; Yildiz F
    J Contemp Brachytherapy; 2020 Feb; 12(1):35-43. PubMed ID: 32190068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic effect of tumor volume, reduction ratio, and cumulative doses on external beam radiotherapy with central-shielding method and image-guided adaptive brachytherapy for cervical cancer.
    Ohtaka T; Ando K; Oike T; Noda SE; Kaminuma T; Murata K; Ohno T
    Front Oncol; 2024; 14():1366777. PubMed ID: 38774419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
    Chi Y; Pan Y; Zhang N; Han D; Guo X; Mao Z; Cheng G
    Front Oncol; 2022; 12():841980. PubMed ID: 35372065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy.
    Dimopoulos JC; Pötter R; Lang S; Fidarova E; Georg P; Dörr W; Kirisits C
    Radiother Oncol; 2009 Nov; 93(2):311-5. PubMed ID: 19679365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
    Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Moerland MA; Witteveen PO; Schreuder HW; van Dorst EB; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Horeweg N; Creutzberg CL; Rijkmans EC; Laman MS; Velema LA; Coen VLMA; Stam TC; Kerkhof EM; Kroep JR; de Kroon CD; Nout RA
    Int J Gynecol Cancer; 2019 Feb; 29(2):257-265. PubMed ID: 30630883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric impact of target definition in brachytherapy for cervical cancer - Computed tomography and trans rectal ultrasound versus magnetic resonance imaging.
    Swamidas J; Jain J; Nesvacil N; Tanderup K; Kirisits C; Schmid M; Agarwal P; Joshi K; Naga P; Ranjan Khadanga C; Gudi S; Gurram L; Chopra S; Mahantshetty U
    Phys Imaging Radiat Oncol; 2022 Jan; 21():126-133. PubMed ID: 35257030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commissioning of applicator-guided stereotactic body radiation therapy boost with high-dose-rate brachytherapy for advanced cervical cancer using radiochromic film dosimetry.
    Aldelaijan S; Wadi-Ramahi S; Nobah A; Moftah B; Devic S; Jastaniyah N
    Brachytherapy; 2017; 16(4):893-902. PubMed ID: 28457741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Volumetric Independent Dose Calculation System for Verification of the Treatment Plan in Image-Guided Adaptive Brachytherapy.
    Kang SW; Chung JB; Kim KH; Park JY; Park HJ; Cho W; Olberg S; Suh TS; Park JC
    Front Oncol; 2020; 10():609. PubMed ID: 32477931
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Number of Needle Applicators Inserted in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer.
    Hirai R; Ohta T; Igari M; Kumazaki YU; Iino M; Aoshika T; Ryuno Y; Saito S; Abe T; Noda SE; Kato S
    Anticancer Res; 2023 Jul; 43(7):3265-3271. PubMed ID: 37351988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Hyaluronate Acid Injection on Dose-Volume Parameters in Brachytherapy for Cervical Cancer.
    Kobayashi R; Murakami N; Chiba T; Okuma K; Inaba K; Takahashi K; Kaneda T; Kashihara T; Takahashi A; Shimizu Y; Nakayama Y; Kato T; Ito Y; Igaki H
    Adv Radiat Oncol; 2022; 7(3):100918. PubMed ID: 35647394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of computed tomography- and magnetic resonance imaging-based target delineation for cervical cancer brachytherapy.
    Wang F; Bu L; Wu Q; Jiang X; Wu L; Li Y; Xi B; Lu Z; Yan S
    J Contemp Brachytherapy; 2020 Aug; 12(4):367-374. PubMed ID: 33293976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.